News Author: Sara Freeman Publish date: April 26, 2016
An investigational drug that targets the hepatitis B virus (HBV) core protein is a “totally new approach” to treating chronic HBV infection according ...
News Author: Sara Freeman Publish date: April 22, 2016
The monoclonal antibody vedolizumab may reduce biliary inflammation in patients with primary sclerosing cholangitis and comorbid inflammatory bowel di...
News Author: Sara Freeman Publish date: April 20, 2016
Key clinical point: A single intra-articular injection of TissueGene C provided symptomatic relief and could be the first disease-modifying osteoa...
News Author: Sara Freeman Publish date: April 19, 2016
A modified form of ursodeoxycholic acid could offer patients with primary sclerosing cholangitis the first real pharmacologic treatment option, it was...
News Author: Sara Freeman Publish date: April 16, 2016
BARCELONA – Although a new histological scoring system was able to predict mortality from nonalcoholic fatty liver disease (NAFLD), fibrosis remains t...
News Author: Sara Freeman Publish date: April 14, 2016
Key clinical point: Acetaminophen has minimal effects on pain and physical function in patients with hip and knee osteoarthritis. Major finding: Do...
News Author: Sara Freeman Publish date: April 14, 2016
Key clinical point: Contrary to guidelines, physical therapy is being underused as a first treatment option for osteoarthritis.
Major finding: Onl...
News Author: Sara Freeman Publish date: April 14, 2016
Key clinical point: Weight and physical inactivity are potentially modifiable risk factors for low back pain.
Major finding: The risk for low back...
News Author: Sara Freeman Publish date: April 14, 2016
Key clinical point: Weight and physical inactivity are potentially modifiable risk factors for low back pain.
Major finding: The risk for low back...
News Author: Sara Freeman Publish date: April 13, 2016
Key clinical point: Distinct serum biomarker panels have been identified for OA progression and diagnosis.
Major finding: The predictive power of ...
News Author: Sara Freeman Publish date: April 9, 2016
Understanding how osteoarthritis hip pain changes over time may help manage those who experience severe pain.
News Author: Sara Freeman Publish date: April 9, 2016
Key clinical point: A single intra-articular injection of FX006 provided pain relief for up to 12 weeks.
Major finding: The mean daily pain inten...
News Author: Sara Freeman Publish date: April 8, 2016
Key clinical point: Several signs and symptoms could be used to help identify patients with osteoarthritis (OA) up to 5 years before joint damage ...
News Author: Sara Freeman Publish date: April 8, 2016
Key clinical point: Several signs and symptoms could be used to help identify patients with osteoarthritis (OA) up to 5 years before joint damage ...
News Author: Sara Freeman Publish date: April 8, 2016
Key clinical point: Patients with milder osteoarthritis can fare worse after knee replacement surgery, and the cost-effectiveness of the procedure ...
